Please use this identifier to cite or link to this item:
http://repo.knmu.edu.ua/handle/123456789/2492Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Demydenko, Ganna | - |
| dc.contributor.author | Kovalyova, Olga | - |
| dc.contributor.author | Kochubiei, Oksana | - |
| dc.date.accessioned | 2012-12-14T11:46:52Z | - |
| dc.date.available | 2012-12-14T11:46:52Z | - |
| dc.date.issued | 2012 | - |
| dc.identifier.citation | Demydenko G. Inflammation biomarkers in hypertensive patients with prediabetes / G. Demydenko, O. Kovalyova, O. Kochubei // Journal of Hypertension. – 2012. – Vol. 30, Supl. A, April. – P. 613. | uk_UK |
| dc.identifier.uri | https://repo.knmu.edu.ua/handle/123456789/2492 | - |
| dc.description.abstract | Inflammatory mechanisms play a key role in the pathogenesis of diabetes mellitus. Tumor necrosis factor-α (TNF-α) and Interleukin-6 (IL-6) are two major proinflammatory markers or cytokines, acting primarily as autocrine and/or paracrine factors. IL-6 independently predicts the risk of type 2 diabetes. However, IL-6b causal role in the development of diabetes is still unclear. | uk_UK |
| dc.language.iso | en | uk_UK |
| dc.subject | Inflammation biomarkers | uk_UK |
| dc.subject | prediabetes | uk_UK |
| dc.title | Inflammation biomarkers in hypertensive patients with prediabetes | uk_UK |
| dc.type | Article | uk_UK |
| Appears in Collections: | Наукові праці. Кафедра пропедевтики внутрішньої медицини № 1, основ біоетики та біобезпеки | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| отправлено 2 London 29_04_2012.doc | 24 kB | Microsoft Word | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.